Zagaroli A M, Zimmer S M, Bowes J M, Hartley K S
Bronson Methodist Hospital, Bronson Nephrology, Kalamazoo, Michigan, USA.
Adv Perit Dial. 1995;11:254-7.
We wanted continuous ambulatory peritoneal dialysis (CAPD) and continuous cycling peritoneal dialysis (CCPD) patients to become more cognitive of the complications of high-serum phosphorus levels (> 6.0 mg/dL). The phosphorus self-monitoring program was designed to encourage patients to be more responsible for preventing the complications of renal osteodystrophy. Patients' phosphorus levels were graphed monthly on a poster in the exam room. Additional posters discussed their responsibilities to control phosphorus and the complications associated with hyperphosphatemia. All patients received an informative letter regarding the inception of the program in March 1994 and also were assured total anonymity of their laboratory results. At monthly clinic appointments, they received additional written information on phosphorus and discussed their phosphorus levels. Our teaching method proved effective in our CAPD/CCPD population. In March 1994, 31% of our patients had a phosphorus level greater than 6.0 mg/dL versus 10% in September 1994. The ability of patients to see their monthly progress and the comparison with other patients encouraged much interest and questions regarding phosphorus control.
我们希望持续性非卧床腹膜透析（CAPD）和持续性循环腹膜透析（CCPD）患者能更多地了解高血清磷水平（>6.0毫克/分升）的并发症。磷自我监测项目旨在鼓励患者在预防肾性骨营养不良并发症方面承担更多责任。患者的磷水平每月都会绘制在检查室的一张海报上。其他海报则讨论了他们控制磷的责任以及与高磷血症相关的并发症。所有患者都收到了一封关于该项目于1994年3月启动的信息信，并且其实验室结果也得到了完全保密的保证。在每月的门诊预约中，他们会收到关于磷的更多书面信息，并讨论自己的磷水平。我们的教学方法在我们的CAPD/CCPD患者群体中被证明是有效的。1994年3月，我们31%的患者磷水平高于6.0毫克/分升，而1994年9月这一比例为10%。患者查看自己每月进展情况以及与其他患者进行比较的能力激发了他们对磷控制的浓厚兴趣和诸多问题。
